Target intelligence / Profile preview

T cell receptor alpha joining 59 (non-functional) (TRAJ59)

Target
TRAJ59
Molecular classification
T cell receptor gene segment, Other
01

Overview

T cell receptor alpha joining 59 (TRAJ59) is a gene segment within the T cell receptor (TCR) alpha locus that is classified as "non-functional," encoding a joining (J) segment that does not produce a functional protein product. T cell receptors are assembled during T cell development through somatic recombination of gene segments, including variable (V), joining (J), and constant (C) regions; each specific TCR alpha chain requires successful V-J recombination. As a non-functional J gene segment, TRAJ59 does not contribute directly to functional TCR proteins and is not itself a therapeutic drug target, receptor, or enzyme. Its main role is as part of the genomic architecture that enables TCR diversity. Key notes: - The "non-functional" annotation means this segment does not encode a protein incorporated into TCRs. - Not a "receptor" or therapeutic target in the protein sense—rather, it is a genomic element used in antigen receptor gene rearrangement. - No associated drugs, biomarkers, or safety concerns. - TRAJ59 is part of T cell receptor gene family segments, specifically the alpha chain joining region. - If you meant the assembled TCR alpha chain (and not its genomic J segment), information would differ. TRAJ59 itself is not a protein-coding drug or therapeutic target. If you intended to inquire about the functional T cell receptor alpha chain rather than this specific J segment, clarification may be needed.

Other names
TRAJ59T cell receptor alpha joining 59 (non-functional)IMGT/TRAJ59
02

Biological functions

T cell receptor diversity/repertoire (gene segment contributing to TCR alpha chain diversity, not a functional protein itself)
03

Disease associations

Other (no direct disease role; not a therapeutic target, but involved as a genomic segment in T cell receptor formation)

Beyond the preview

Go deeper on T cell receptor alpha joining 59 (non-functional) (TRAJ59).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha joining 59 (non-functional) (TRAJ59).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call